Evidence map›Paper›PMID 24772091›Full record

ReviewFrontiers in physiology2014

Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus.

Carla C C R de Carvalho, Sofia S Costa, Pedro Fernandes, Isabel Couto, Miguel Viveiros

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. Cooperation BetweenMicroorganisms · 2024
    Article
  6. Article
  7. Genome-Based Exploration ofMicroorganisms · 2022
    Article
  8. Frontiers in microbiology · 2022
    Review
  9. Review
  10. Detection ofPathogens (Basel, Switzerland) · 2021
    Article
  11. Antibiotics (Basel, Switzerland) · 2020
    Article
  12. Article
  13. Antibiotic resistance genes in the Actinobacteria phylum.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. 3-Hydroxybenzoate 6-Hydroxylase fromFrontiers in microbiology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Carla C C R de CarvalhoDepartment of Bioengineering, Centre for Biological and Chemical Engineering, Institute of Biotechnology and Bioengineering, Instituto Superior Técnico, Universidade de Lisboa Lisboa, Portugal.
Sofia S CostaGrupo de Micobactérias, Unidade de Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa Lisboa, Portugal ; Centro de Recursos Microbiológicos, Universidade Nova de Lisboa Caparica, Portugal.
Pedro FernandesDepartment of Bioengineering, Centre for Biological and Chemical Engineering, Institute of Biotechnology and Bioengineering, Instituto Superior Técnico, Universidade de Lisboa Lisboa, Portugal.
Isabel CoutoGrupo de Micobactérias, Unidade de Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa Lisboa, Portugal ; Centro de Recursos Microbiológicos, Universidade Nova de Lisboa Caparica, Portugal.
Miguel ViveirosGrupo de Micobactérias, Unidade de Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa Lisboa, Portugal ; Centro de Malária e Outras Doenças Tropicais, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa Lisboa, Portugal.
Universidade Nova de Lisboa · PTInstitute for Biotechnology and Bioengineering · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Rhodococcus genus contains species with remarkable ability to tolerate toxic compounds and to degrade a myriad of substrates. These substrates have to cross a distinctive cell envelope dominated by mycolic acids anchored in a scaffold of arabinogalactan covalently attached to the cell wall peptidoglycan, and a cellular membrane with phospholipids, whose composition in fatty acids can be rapidly altered in response to environmental conditions. The hydrophobic nature of the cell envelope facilitates the entrance of hydrophobic molecules but some substrates require active transport systems. Additionally, toxic compounds may also be extruded by energy spending efflux systems. In this review, physiological evidences of the use of transport systems by Rhodococcus strains and genomic studies that corroborate their existence are presented and discussed. The recently released complete genomes of several Rhodococcus strains will be the basis for an in silico correlation analysis between the efflux pumps present in the genome and their role on active transport of substrates. These transport systems will be placed on an integrative perspective of the impact of this important genus on biotechnology and health, ranging from bioremediation to antibiotic and biocide resistance.

Indexed as

antimicrobialsefflux inhibitorsefflux pumpsrhodococcisolvents

Identifiers

PMID24772091
PMCPMC3983516
OpenAlexW2132046087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.